Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
97.621,94
-0,60%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 60 Degrees Pharmaceuticals Inc (SXTPW) 60 Degrees Pharmaceuticals Inc (SXTPW) Notizie

60 Degrees Pharmaceuticals Inc

SXTPW
0,027
0,0011 (4,25%)
03 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/12/202414:57GLOBESixty Degrees Pharmaceuticals and Tufts Medical Center..
19/12/202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202414:56GLOBE60 Degrees Pharmaceuticals Expands Tafenoquine Clinical..
09/12/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202420:31GLOBE60 Degrees Pharmaceuticals Announces Third Quarter 2024..
14/11/202419:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202423:26EDGAR2Form 8-K - Current report
15/10/202421:46EDGAR2Form DEF 14A - Other definitive proxy statements
08/10/202414:17EDGAR2Form 8-K - Current report
03/10/202415:02GLOBE60 Degrees Pharmaceuticals Inc. Announces ARAKODA®..
02/10/202416:56EDGAR2Form PRE 14A - Other preliminary proxy statements
01/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/9/202422:30EDGAR2Form S-3 - Registration statement under Securities Act of..
11/9/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202422:10EDGAR2Form 8-K - Current report
06/9/202414:59GLOBE60 Degrees Pharmaceuticals, Inc. Announces Closing of $4..
04/9/202414:00GLOBE60 Degrees Pharmaceuticals, Inc. Announces $4 Million..
28/8/202420:48GLOBE60 Degrees Pharmaceuticals, Inc. Regains Compliance with..
14/8/202417:01GLOBE60 Degrees Pharmaceuticals Announces Second Quarter 2024..
12/8/202415:12GLOBE60 Degrees Pharma Provides University of Kentucky with Right..
06/8/202415:26GLOBE60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse..
25/7/202415:02GLOBE60 Degrees Pharmaceuticals Awarded Contract with U.S. Army..
19/7/202414:29GLOBE60 Degrees Pharmaceuticals Signs Clinical Trial Agreements..
09/7/202412:31GLOBE60 Degrees Pharma Announces IRB Approval of Clinical Study..
27/6/202413:59GLOBEFirst Patient Enrolled in 60 Degrees Pharmaceuticals..
12/6/202423:26EDGAR2Form 8-K - Current report
11/6/202413:59GLOBE60 Degrees Pharmaceuticals Receives FDA Orphan Drug..
30/5/202420:15EDGAR2Form DEF 14A - Other definitive proxy statements
30/5/202413:59GLOBEEnrollment in 60 Degrees Pharmaceuticals Clinical Trial of..
22/5/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202402:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202402:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202413:59GLOBE60 Degrees Pharmaceuticals Funds Babesia spp Testing in..
15/5/202419:45GLOBE60 Degrees Pharmaceuticals Announces First Quarter 2024..
15/5/202417:56EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:59GLOBE60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial..
02/5/202413:59GLOBE60 Degrees Pharmaceuticals Receives FDA Comments on..
03/4/202413:58GLOBE60 Degrees Pharmaceuticals to Sponsor Pilot Study of..
14/3/202412:59GLOBE60 Degrees Pharmaceuticals Announces Communication from the..
20/2/202413:59GLOBE60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies..
08/2/202413:59GLOBE60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief..
31/1/202417:15GLOBE60 Degrees Pharmaceuticals Announces Closing of $2.4 Million..
30/1/202415:00GLOBE60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million..
22/1/202413:59GLOBE60 Degrees Pharma Plans Pivotal Babesiosis Study with..
16/1/202413:59GLOBE60 Degrees Pharma Regains Compliance with Nasdaq Listing..
Apertura: 0,025 Min: 0,025 Max: 0,027
Chiusura: 0,0259

La tua Cronologia

NASDAQ
SXTPW
60 Degrees Pharmaceuticals
USOTC
AVVNF
Avia Avian TBK PT (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network